Adults with diabetes who meet the recommended guidelines for physical activity may offset the risk of mortality that is associated with excessive sitting time, according to a new study at Columbia University Mailman School of Public Health. This is the first study to show that getting adequate exercise can counteract the elevated risk of mortality associated with sitting for long periods of time each day, even for people with diabetes. The findings are published in Diabetes Care.

“Managing the elevated mortality risk in this high-risk population is particularly pressing given the widespread diabetes epidemic and the tendency among adults with diabetes to sit more and move less,” said Wen Dai, PhD, first author who was a doctoral student in Epidemiology at Columbia Mailman School.

Excessive sedentary time is a significant public health issue with increased mortality risk for the general population.

The researchers analyzed data from the 2007-2018 National Health and Nutrition Examination Surveys (NHANES) for individuals 20 years of age or older with diabetes as defined by the American Diabetes Association. Individuals with diabetes were followed- through 2019 to determine mortality status. Sitting time and moderate-to-vigorous physical activity were self-reported. Data on sociodemographics, lifestyle factors and medical conditions were collected through computer-assisted personal interviews.

Physical activity was categorized as inactive (

Over approximately 6 years, there were 1,278 deaths from all causes and 354 deaths from heart disease for individuals 60 years old on average, 48 percent of whom were female and 61 percent non-Hispanic White. About one-quarter had less than a high school education, and approximately 12 percent lacked health insurance.

“Our findings support an emphasis on encouraging and supporting patients in adhering to guideline-recommended physical activity levels, particularly for individuals whose life circumstances necessitate prolonged sitting in particular, such as drivers or office workers,” said Sandra Albrecht, PhD, assistant professor of Epidemiology at Columbia Mailman School of Public Health, and senior author.

The study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (K01DK107791).



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Before you post, please prove you are sentient.

what is 5 plus 9?

Explore More

Inhibiting somatostatin may prevent dangerous blood glucose drops in type 1 diabetes

Impact of T1D on plasma glucose and pancreatic insulin and glucagon contents in NOD mice. Credit: Nature Metabolism (2024). DOI: 10.1038/s42255-024-01139-z Inhibiting the hormone somatostatin may be a new treatment

New diabetes research links blood glucose levels and voice pitch

Glucose profiles of comprehensive and sampled CGM data corresponding to voice recordings. (a–c): Comprehensive CGM glucose profiles of ND, PD, T2D. (d–f): Sampled CGM data corresponding to voice recordings of

Just a moment…

Just a moment… Enable JavaScript and cookies to continue This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until